Folks who like to stay up late are nearly 50% more likely to develop type 2 diabetes than those who go to bed earlier, a new study finds. However, it’s not just because they have an unhealthy lifestyle, according to findings presented Sunday at the annual meeting of the European Association for the Study of… read on > read on >
.jpg)
Losing weight can help a person with obesity — especially those with diabetes — fend off serious infections, new data shows. It’s an important finding, since “up to one in three hospitalizations in people with diabetes are for infections and people with diabetes are twice as likely to be hospitalized with infections than the general… read on > read on >
A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the weekly injections they now take, a new study demonstrates. The new formulation encases semaglutide in a hydrogel that slowly releases the drug as the gel dissolves, researchers said. “A small dollop of gel,… read on > read on >
PFAS “forever chemicals” could cause pregnant women to experience long-term weight gain, increasing their risk of obesity in middle age, a new study warns. Women with higher levels of PFAS in their blood during early pregnancy weighed more at the age of 50 than those with low levels, researchers reported Sept. 5 in the Journal… read on > read on >
The maker of the ADHD drug Vyvanse has been given approval by the U.S. Drug Enforcement Administration to make more of the medication as a shortage of the critical drugs continues. Following a request from the U.S. Food and Drug Administration in July, the DEA said Thursday that Takeda Pharmaceuticals may now increase its production… read on > read on >
Too many U.S. seniors are skipping their prescription meds due to cost, and the problem is most acute among the poor and chronically ill, new data shows. Almost all (88.6%) Americans age 65 or older have been prescribed at least one prescription medicine, according to 2021-2022 data from an annual federal survey. That percentage rises… read on > read on >
.jpeg)
An overgrowth of gut microorganisms that produce methane could be a cause of severe constipation in many people, a new review finds. These gut bugs belong to a class of microbe called archaea, and when they flourish too well in a person’s gut they cause a condition called intestinal methanogen overgrowth (IMO), researchers explained. People… read on > read on >
The booming popularity of the weight-loss drug semaglutide has prompted increasing concerns about potential side effects from taking Ozempic or Wegovy. But a new study rules out one possible problem — using semaglutide does not increase a person’s risk of depression or suicide, researchers report. Semaglutide did not increase the risk of depression, suicidal thoughts… read on > read on >
Folks taking weight-loss drugs like Wegovy or Zepbound might think they’ve found a shortcut to better health. But they still need to eat a high-quality diet if they want to maintain their well-being while they shed pounds, says a doctor with the University of Texas Southwestern. “One common misconception about these medications is that they’re… read on > read on >
FRIDAY, Aug.30, 2024New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways. These two injected drugs are versions of semaglutide. In multiple new data analyses, the drugs appeared to cut people’s odds for heart failure and its complications, reduce deaths from COVID-19 and lower… read on > read on >
